Skip to main content
. 2018 Sep 30;22(3):184–190. doi: 10.5114/wo.2018.78940

Table 1.

Clinical and laboratory data of patients who underwent hepatic resections before propensity score matching and after propensity score matching

Characteristic Subcuticular suture Mattress suture p-value
Before PSM n = 577 n = 603
Age, years, median (range) 69 (0–89) 67 (21–89) 0.002*
Gender, male, n (%) 371 (64.3) 406 (67.3) 0.255
BMI, kg/m2, median (range) 22.6 (11.9–34.9) 22.2 (14.9–36.2) 0.257
Smoking, n (%) 308 (53.5) 263 (43.6) 0.014*
Hepatitis viral infection, n (%) 234 (40.6) 301 (49.9) 0.001*
Diabetes mellitus, n (%) 154 (26.7) 118 (19.6) 0.004*
HCC/Metastasis, others 256/321 326/277 0.001*
Albumin, g/dl, median (range) 4.0 (2.0–5.2) 4.0 (1.8–5.2) 0.004*
Platelet count, ×104/µl, median (range) 19.0 (1.9–76.5) 19.3 (2.9–69.1) 0.340
Child-Pugh classification, A, n (%) 560 (97.1) 543 (90.0) < 0.001*
Number of tumours 1 (1–24) 1 (1–13) 0.010*
Size of largest tumour (cm) 2.8 (0.5–18.9) 3.2 (0.8–21.0) 0.161
Repeat operation, n 123 (21.3) 72 (11.9) < 0.001*
Type of hepatic resection, n (%)
 Lobectomy
 Segmentectomy
 Partial resection

101 (17.5)
108 (18.7)
368 (63.8)

167 (27.7)
150 (24.9)
286 (47.4)
< 0.001*
Operative time (min) 208 (30–980) 335 (50–1510) < 0.001*
Blood loss (ml) 210 (0–10970) 468 (0–21770) < 0.001*
Blood transfusion (%) 134 (23.2) 140 (23.2) 0.977
Intraoperative abdominal drainage (%) 235 (40.8) 332 (55.1) < 0.001*
Duration of antibiotics (day) 3 (1–14) 2 (1–13) < 0.001*
After PSM n = 121 n = 121
Age, years, median (range) 69 (28–85) 69 (29–89) 0.790
Gender, male, n (%) 81 (66.9) 78 (64.5) 0.685
BMI, kg/m2, median (range) 22.3 (13.9–32.9) 22.2 (16.9–36.2) 0.657
Smoking, n (%) 66 (54.6) 55 (45.5) 0.157
Hepatitis viral infection, n (%) 59 (48.8) 61 (50.4) 0.898
Diabetes mellitus, n (%) 29 (24.0) 27 (22.3) 0.761
HCC/Metastasis, others 66/55 68/53 0.796
albumin, g/dl, median (range) 4.0 (2.9–5.2) 4.0 (1.8–4.9) 0.933
Platelet count, ×104/µl, median (range) 19.3 (2.6–42.2) 18.2 (3.5–45.5) 0.258
Child-Pugh classification, A, n (%) 118 (97.5%) 115 (95.0) 0.308
Number of tumours 1 (1–10) 1 (1–12) 0.602
Size of largest tumour (cm) 2.8 (0.6–12.5) 2.8 (0.8–13.0) 0.424
Repeat operation, n (%) 21 (17.4%) 22 (18.2) 0.867
Type of hepatic resection, n (%)
 Lobectomy
 Segmentectomy
 Partial resection

15 (12.4)
30 (24.8)
76 (62.8)

9 (7.4)
30 (24.8)
82 (67.8)
0.422
Operative time (min) 254 (38–666) 275 (50–505) 0.511
Blood loss (ml) 230 (0–9340) 330 (0–2915) 0.993
Blood transfusion, n (%) 22 (18.2) 24 (19.8) 0.870
Intraoperative abdominal drainage, n (%) 51 (42.2) 50 (41.3) 0.896
Duration of antibiotics (day) 1 (1–7) 2 (1–13) 0.659
*

p < 0.05; BMI – body mass index

HCC – hepatocellular carcinoma; PSM – propensity score matching